CD276 and head and neck squamous cell carcinoma: Both EGFR and CD276 were found highly expressed in Cluster 1, indicating that HNSCC of Cluster 1 were more likely to correlate with worse biological behavior, poorer clinical result, and insensitivity to ICIs-based immunotherapy.